Dr Kate Fife is a consultant clinical oncologist at Addenbrookes Hospital, Cambridge where she was appointed in 2001. Together with Prof Tim Eisen and colleagues, she runs a large research focused renal cancer clinic, seeing approximately 120 new patients per year, making it one of the largest specialist centres for this cancer in the UK.
Her other interests are drug and radiotherapy treatment of skin malignancies. She treats basal cell and squamous cell cancers of the skin and patients with rare skin cancers such as Merkel’s cell cancercutaneous lymphomas and Kaposi’s sarcoma. She also treats patients with melanoma who require radiotherapy.
Kate is an experienced clinical trial principal investigator, running trials in targeted therapy and immunotherapy research in kidney cancer, and translational studies in skin and kidney cancer.
Kate is an associate lecturer at Cambridge University. She is a member of the National Cancer Research Institute Kidney cancer Clinical Studies Group and the Kidney Cancer UK Quality Improvement Group. She is on the British Association of Dermatologists Guideline development group for skin cancers. She is also interested in training and is an educational supervisor. Kate trained in medicine at St George’s Hospital in London, qualifying in 1987. She trained in general medicine then in oncology initially at the Royal Marsden Hospital.
Kate carried out clinical research in HIV related malignancies whilst a research fellow at Chelsea and Westminster and Charing Cross Hospitals and completed an MD in angiogenesis related laboratory research in 1998. She completed her oncology training at the Hammersmith Hospital. Subsequently she was a locum Consultant and research fellow at the Sydney Cancer Centre and Sydney Melanoma Unit, carrying out further laboratory and clinical research.
Kate has clinics at Spire Cambridge Lea Hospital.